SCHEMBL25059246

SCHEMBL25059246

CNC(C)c1ccc(C#CC#CCOCC(C)(C)C)cc1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 19/20 0.34
▸ ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26328570 0.88 ACACB (0.34) ACACB
SCHEMBL18591835 0.88 ACACB (0.34) ACACB
SCHEMBL21214847 0.86 GRM5 (0.34) ACACB
SCHEMBL18551308 0.85 ACACB (0.40) ACACB
SCHEMBL18551220 0.84 ACACB (0.34) ACACBALDH1A1
SCHEMBL24920843 0.82 ACACB (0.33) ACACB
SCHEMBL21664699 0.80 ACACB (0.41) ACACB
SCHEMBL20133165 0.79 ACACB (0.38) ACACB
SCHEMBL21906682 0.76 ACACB (0.36) ACACB
SCHEMBL26748745 0.73 ACACB (0.39) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3660004-B1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR ARVINAS OPERATIONS INC (US) 2023-02-22 — — EP disclosed
Send feedback